Showing 1661-1670 of 10612 results for "".
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
https://reachmd.com/programs/cme/expert-answers-to-common-questions-about-met-exon-14skipping-mutations-in-nsclc/14678/Join an expert panel as they answer key questions about MET exon 14–skipping mutations in non-small cell lung cancer.PH Management in Unique Patients and Conditions
https://reachmd.com/programs/cme/ph-management-in-unique-patients-and-conditions/36096/Experts discuss addressing challenges that may come with managing patients with pulmonary hypertension (PH) in unique patient populations and with complex conditions.Mastering Mutation-Driven mCRC: From Testing to Targeted Therapy
https://reachmd.com/programs/cme/mastering-mutation-driven-mcrc-from-testing-to-targeted-therapy/32374/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
https://reachmd.com/programs/cme/optimizing-outcomes-in-patients-with-ohcm-the-emerging-role-of-cardiac-myosin-inhibitors/33176/Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin InhibitorsRedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
https://reachmd.com/programs/cme/redefining-immunotherapy-access-integrating-subcutaneous-checkpoint-inhibitors-across-solid-tumors/56117/How are SC immune checkpoint inhibitors changing care in solid tumors? Hear a physician–nurse interview and explore implications for your practice.From Pixels to Practice: Advancing HCM Care With Multimodality Imaging
https://reachmd.com/programs/cme/from-pixels-to-practice-advancing-hcm-care-with-multimodality-imaging/39877/Explore how multimodality imaging advances diagnosis, treatment selection, and monitoring in hypertrophic cardiomyopathy care.New Insights in the Management of HCM: Exploring the Clinical Spectrum
https://reachmd.com/programs/cme/new-insights-in-the-management-of-hcm-exploring-the-clinical-spectrum/33026/Explore personalized strategies in obstructive HCM, from diagnosis to treatment evolution, including real-world insights into cardiac myosin inhibitor use.Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
https://reachmd.com/programs/cme/missing-the-window-in-ambulatory-patients-with-hfref-on-gdmt-strategies-for-cv-risk-reduction/48813/What is the optimal timing for adding evidence-based therapies beyond GDMT in patients with HFrEF? Explore this topic with Drs. Greene and Savarese.Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
https://reachmd.com/programs/cme/optimizing-igan-care-achieving-lower-proteinuria-targets-with-combination-therapy/26631/Review data on combination therapy with sparsentan and SGLT2 inhibitors to achieve lower proteinuria in patients with IgA nephropathy.Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
https://reachmd.com/programs/cme/continuity-in-care-strategies-for-managing-growth-hormone-deficiency-through-lifes-stages/35523/Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages